StreetAlpha
Ocular Therapeutix, Inc · SEC Form 4

OCUL Insider Trading

From SEC Form 453 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Ocular Therapeutix, Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $461K bought and $3.3M sold.

← OCUL stock page

Insiders are net sellers
Bought, 12 months$461K1 buys · 1 insiders
Sold, 12 months$3.3M28 sales · 8 insiders
Net−$2.8Mbought minus sold
Planned sales93%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJan2026-02: bought $461K2026-02: sold $1.8MFebMarApr2026-05: sold $238KMay2026-06: sold $123KJunJul2026-08: sold $333KAugSep2026-10: sold $234KOct2026-11: sold $232KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when OCUL insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an OCUL officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every OCUL insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 5, 2026Namrata SarojChief Business OfficerSale plan35,370$6.55$232K220,522Nov 9Form 4
Oct 8, 2026Todd AndermanChief Legal OfficerSale plan11,984$7.29$87K140,484Oct 13Form 4
Oct 2, 2026Jeffrey S. HeierChief Scientific OfficerSale plan10,869$7.05$77K307,457Oct 6Form 4
Oct 2, 2026Peter KaiserChief Development OfficerSale plan9,990$7.05$70K254,388Oct 6Form 4
Aug 31, 2026Donald NotmanCOOSale1,099$10.24$11K366,529Sep 2Form 4
Aug 24, 2026Pravin DugelSee RemarksSale plan21,649$10.77$233K2,525,429Aug 26Form 4
Aug 24, 2026Jeffrey S. HeierChief Scientific OfficerSale plan3,296$10.78$36K318,326Aug 26Form 4
Aug 24, 2026Sanjay NayakChief Strategy OfficerSale plan1,897$10.78$20K326,898Aug 26Form 4
Aug 24, 2026Peter KaiserChief Development OfficerSale plan3,035$10.77$33K264,378Aug 26Form 4
Jun 3, 2026Nadia WaheedChief Medical OfficerSale plan14,828$8.27$123K300,079Jun 5Form 4
May 26, 2026Sanjay NayakChief Strategy OfficerSale plan1,858$8.20$15K328,795May 28Form 4
May 26, 2026Jeffrey S. HeierChief Scientific OfficerSale plan3,018$8.20$25K320,350May 28Form 4
May 26, 2026Peter KaiserChief Development OfficerSale plan2,967$8.20$24K266,141May 28Form 4
May 26, 2026Pravin DugelSee RemarksSale plan21,156$8.20$173K2,597,170May 28Form 4
Feb 23, 2026Sanjay NayakChief Strategy OfficerSale plan1,759$8.28$15K330,653Feb 25Form 4
🔒 38 more trades. Create a free account or sign in to see them all.

OCUL insider trading FAQ

Are OCUL insiders buying or selling?

Insiders are net sellers over the last 12 months. 1 insiders bought $461K of OCUL on the open market in 1 trades, and 8 sold $3.3M in 28 trades, 93% of that under pre-arranged trading plans.

When did an OCUL insider last buy shares?

Richard L Lindstrom Md (Director) bought 60,229 shares for $461K on Feb 20, 2026, reported on Feb 24, 2026.

When did an OCUL insider last sell shares?

Namrata Saroj (Chief Business Officer) sold 35,370 shares for $232K on Nov 5, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice